PROTO SCRIPT PHARMACEUTICAL CORP Revenue, Net (Deprecated 2018-01-31)
PROTO SCRIPT PHARMACEUTICAL CORP reported Revenue, Net (Deprecated 2018-01-31) of $251.97 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2018-03-08.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-03-08
- PROTO SCRIPT PHARMACEUTICAL CORP revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $251.97K, a 17.84% increase year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $114.37K, a 13.07% decline year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP revenue, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $138.28K, a 59.71% decline year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP revenue, net (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $100.35K, a 53.05% decline year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP revenue, net (deprecated 2018-01-31) for fiscal 2016 was $788.96K, a 10.49% decline from fiscal 2015.
- PROTO SCRIPT PHARMACEUTICAL CORP revenue, net (deprecated 2018-01-31) for fiscal 2015 was $881.44K.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-09-30 | $251.97K 10-Q · filed 2018-03-08 | $366.35K derived: sum of 2 quarters · filed 2018-03-08 | $504.63K 10-Q · filed 2018-03-08 | $604.98K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-06-30 | $114.37K 10-Q · filed 2018-01-17 | $252.66K 10-Q · filed 2018-01-17 | $353.00K derived: sum of 3 quarters · filed 2018-01-17 | $566.83K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-03-31 | $138.28K 10-Q · filed 2017-11-22 | $238.63K derived: sum of 2 quarters · filed 2017-11-22 | $452.46K derived: sum of 3 quarters · filed 2018-03-08 | $584.03K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-12-31 | $100.35K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-10-19 | $314.18K derived: sum of 2 quarters · filed 2018-03-08 | $445.75K derived: sum of 3 quarters · filed 2018-03-08 | $788.96K 10-K/A · filed 2017-10-19 |
| 2016-09-30 | $213.83K 10-Q · filed 2018-03-08 | $345.40K derived: sum of 2 quarters · filed 2018-03-08 | $688.61K 10-Q · filed 2018-03-08 | $902.35K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $131.57K 10-Q · filed 2018-01-17 | $474.79K 10-Q · filed 2018-01-17 | $688.53K derived: sum of 3 quarters · filed 2018-01-17 | $810.80K derived: sum of 4 quarters · filed 2018-01-17 |
| 2016-03-31 | $343.21K 10-Q · filed 2017-11-22 | $556.95K derived: sum of 2 quarters · filed 2017-11-22 | $679.22K derived: sum of 3 quarters · filed 2017-11-22 | $912.90K derived: sum of 4 quarters · filed 2017-11-22 |
| 2015-12-31 | $213.74K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-10-19 | $336.01K derived: sum of 2 quarters · filed 2017-10-19 | $569.69K derived: sum of 3 quarters · filed 2017-10-19 | $881.44K 10-K/A · filed 2017-10-19 |
| 2015-09-30 | $122.27K 10-Q · filed 2017-01-06 | $355.95K derived: sum of 2 quarters · filed 2017-01-06 | $667.70K 10-Q · filed 2017-01-06 | |
| 2015-06-30 | $233.68K 10-Q · filed 2016-11-18 | $545.43K 10-Q · filed 2016-11-18 |